Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Beta1a Nasal Spray for Symptom Control in COVID-19
IRCT20080901001165N53Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- May 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of interferon beta-1a in coronavirus disease 2019 (COVID-19), sponsored by Baqiyatallah University of Medical Sciences. Started May 2020; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20080901001165N53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080901001165N53.